Sign up to save your podcasts
Or
Share Funding the future of retinal health with Eyepoint
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Funding the future of retinal health with Eyepoint
Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence.
View all episodes
By RBC Capital Markets
5
1212 ratings
Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence.
More shows like Pathfinders in Biopharma
View all
Motley Fool Money
3,211 Listeners
WSJ Your Money Briefing
1,708 Listeners
Exchanges
956 Listeners
Odd Lots
1,943 Listeners
WSJ Tech News Briefing
1,645 Listeners
The a16z Show
1,093 Listeners
The Long Run with Luke Timmerman
123 Listeners
The Readout Loud
321 Listeners
Wall Street Breakfast
1,048 Listeners
Thoughts on the Market
1,302 Listeners
The Journal.
6,071 Listeners
BioCentury This Week
33 Listeners
RBC's Markets in Motion
40 Listeners
Biotech Hangout
20 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Markets
80 Listeners
Strategic Alternatives
17 Listeners
The Top Line
12 Listeners
Macro Minutes
3 Listeners